Literature DB >> 9269647

Patient survival after renal transplantation; more than 25 years follow-up.

S M Arend1, M J Mallat, R J Westendorp, F J van der Woude, L A van Es.   

Abstract

BACKGROUND: The determinators of patient survival after renal transplantation are incompletely known, and conflicting results have been reported. This may have been influenced by time-related changes in patient selection, post-transplantation management and immunosuppressive regimens. This study was performed to evaluate in recipients of a first renal transplant the effect of patient characteristics, transplantation era, and the immunosuppressive regimen on patient survival.
METHODS: We used data from the Leiden Renal Transplant Database of all first renal transplantations performed between 1966 and 1994 in Leiden, the Netherlands. The effect of the following parameters on mortality was investigated: era of transplantation, sex, age at transplantation, cause of renal failure, immunosuppressive regimen, type and duration of pretransplantation dialysis, hypertension, diabetes mellitus, and smoking. In addition we analysed the causes of death. Results were expressed as crude mortality rates, relative risks of mortality, and standardized mortality ratios as compared with death rates in the Dutch population.
RESULTS: The analysis comprised 86 living donor transplant recipients and 916 cadaver transplant recipients. After adjustment for age and sex, the relative risk of mortality for living donor transplant recipients compared with cadaver transplant recipients was 0.5 (95% CI 0.2 to 1.03, P = 0.06). In first cadaver kidney transplant recipients the risk of first-year mortality improved significantly with time, which coincided with the introduction of cyclosporin. The risk of mortality after the first year was higher in patients aged over 40 years at transplantation, men, smokers, and in the presence of hypertension or diabetes, but the effect of individual factors on mortality was small. We found no effect of the type of pretransplantation dialysis or the duration of pretransplantation haemodialysis on post-transplantation mortality. The standardized mortality ratio for recipients of first renal transplants was 14 times the population average in the first year after transplantation and was still four times in the remaining years.
CONCLUSION: In the present study, time-related changes in patient management were responsible for improved patient survival in the first year after transplantation during the study period. Many individual factors contributed moderately to the risk of mortality after the first year. Compared to the general population the mortality rate of renal transplant recipients was significantly higher during the whole follow-up period.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9269647     DOI: 10.1093/ndt/12.8.1672

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  41 in total

1.  Kidney Transplantation Outcomes across GN Subtypes in the United States.

Authors:  Michelle M O'Shaughnessy; Sai Liu; Maria E Montez-Rath; Colin R Lenihan; Richard A Lafayette; Wolfgang C Winkelmayer
Journal:  J Am Soc Nephrol       Date:  2016-07-18       Impact factor: 10.121

2.  An unusual complication of renal transplantation: a fistula between the sigmoid colon and the graft.

Authors:  Valerio Masiero; Camillo Orsini; Sara-Maria Tosato; Maurizio Nordio; Emilio Morpurgo
Journal:  Updates Surg       Date:  2012-05-04

3.  Secular Trends in Infection-Related Mortality after Kidney Transplantation.

Authors:  Susanna Kinnunen; Pauli Karhapää; Auni Juutilainen; Patrik Finne; Ilkka Helanterä
Journal:  Clin J Am Soc Nephrol       Date:  2018-04-05       Impact factor: 8.237

Review 4.  Cardiac imaging for the assessment of patients being evaluated for kidney or liver transplantation.

Authors:  Kalindi Parikh; Andrew Appis; Rami Doukky
Journal:  J Nucl Cardiol       Date:  2014-10-08       Impact factor: 5.952

Review 5.  Primary care of the renal transplant patient.

Authors:  Gaurav Gupta; Mark L Unruh; Thomas D Nolin; Peggy B Hasley
Journal:  J Gen Intern Med       Date:  2010-04-27       Impact factor: 5.128

Review 6.  Percutaneous coronary interventions and antiplatelet therapy in renal transplant recipients.

Authors:  Francesco Summaria; Maria Benedetta Giannico; Giovanni Paolo Talarico; Roberto Patrizi
Journal:  Ther Adv Cardiovasc Dis       Date:  2015-12-16

7.  More potent lipid-lowering effect by rosuvastatin compared with fluvastatin in everolimus-treated renal transplant recipients.

Authors:  Ida Robertsen; Anders Asberg; Tone Granseth; Nils Tore Vethe; Fatemeh Akhlaghi; Mwlod Ghareeb; Espen Molden; Morten Reier-Nilsen; Hallvard Holdaas; Karsten Midtvedt
Journal:  Transplantation       Date:  2014-06-27       Impact factor: 4.939

Review 8.  Profile of belatacept and its potential role in prevention of graft rejection following renal transplantation.

Authors:  Gaurav Gupta; Karl L Womer
Journal:  Drug Des Devel Ther       Date:  2010-12-01       Impact factor: 4.162

9.  Local gene therapy with indoleamine 2,3-dioxygenase protects against development of transplant vasculopathy in chronic kidney transplant dysfunction.

Authors:  D Vavrincova-Yaghi; L E Deelman; H van Goor; M A Seelen; P Vavrinec; I P Kema; P Gomolcak; A Benigni; R H Henning; M Sandovici
Journal:  Gene Ther       Date:  2016-07-25       Impact factor: 5.250

10.  Delayed graft function and the risk for death with a functioning graft.

Authors:  Shruti N Tapiawala; Kathryn J Tinckam; Carl J Cardella; Jeffrey Schiff; Daniel C Cattran; Edward H Cole; S Joseph Kim
Journal:  J Am Soc Nephrol       Date:  2009-10-29       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.